Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(3R,4E,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl(N-methylsulfonyl)amino]-pyrimidin-5-yl]-3-hydroxy-4,6-heptadienoic Acid Calcium Salt
Formula:(C22H25FN3O5S)CaMolecular weight:2(563.5) : 40.08Lanicemine dihydrochloride
CAS:<p>Lanicemine dihydrochloride (AZD-6765 dihydrochloride) is an NMDA channel blocker with antidepressant activity and can be used to study neurological diseases.</p>Formula:C13H16Cl2N2Purity:98.37%Color and Shape:SolidMolecular weight:271.19Ro 25-6981 Maleate
CAS:<p>Ro 25-6981 Maleate is an NMDA receptor antagonist used in the study of neurological disorders such as Parkinson's and epilepsy.</p>Formula:C26H33NO6Purity:99.42%Color and Shape:SolidMolecular weight:455.54Pentoxifylline-d6
CAS:Controlled Product<p>Applications A labelled metabolite of Pentifylline. Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Phosphodiesterase inhibitor. Inhibits the synthesis of tumor necrosis factor α (TNF-α).<br>References Ward, A., et al.: Drugs, 34, 50 (1987), Samlaska, C.P., et al.: J. Am. Acad. Dermatol., 30, 603 (1994), Poulakis, et al.: Respir. Med., 93, 52 (1999), Reuter, et al.: Am J. Physiol., 277, 854 (1999),<br></p>Formula:C132H6H12N4O3Color and Shape:NeatMolecular weight:284.34Bimatoprost Acid
CAS:Controlled Product<p>Applications Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost (B386820).Bimatoprost Acid is a metabolically stable analog of PGF2α (P838625) and is a potent agonist for the FP receptor.<br>References Balapure, A.K. et al.: Biochem. Pharmacol., 38, 2375 (1989); Hellberg, M.R. et al.: J. Ocular Pharmacol. Ther., 19, 97 (2003); Krishna, P.M. et al.: J. Pharm. res., 4, 2381 (2011);<br></p>Formula:C23H32O5Color and Shape:White To Off-WhiteMolecular weight:388.50(E)-4-((1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopent-3-en-2-yl)amino)-4-oxobutanoic acid
Formula:C24H27NO5Molecular weight:409.483-Hydroxy-1-methylpyridinium Iodide
CAS:Controlled ProductFormula:C6H8NO·IColor and Shape:NeatMolecular weight:237.043(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
CAS:Controlled Product<p>Applications AMDP3 (4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one) acts as a cardiac troponin effecter, resulting in activation of cardiac muscle contractions. It’s an analogue to Levosimendan (L378000), positive inotropic agent with vasodilating activity.<br>References Sandell, E.-P., et al.: J. Cardiovasc. Pharmacol., 26, S57 (1995), Pagel, P.S., et al.: Cardiovasc. Drug Rev., 14, 286 (1996); Robertson, I. et al.: Biochem., 47, 7485 (2008);<br></p>Formula:C11H13N3OColor and Shape:Light Yellow To BrownMolecular weight:203.24Scopoline Methobromide
CAS:<p>Applications Scopoline Methobromide is an impurity of Tiotropium (T444850), an muscarinic receptor antagonist and bronchodilator.<br>References Moffett, R.B.. et al.: J. Am. Chem. Soc., 77, 1245 (1955); Haddad, E.-B., et al.: Mol. Pharmacol., 45, 899 (1994); Donohue, J. F., et al.: Chest, 122, 47 (2002); Profita, M., et al.: Allergy, 60, 1361 (2005); Dusser, D., et al.: Eur. Respir. J., 27, 547 (2006)<br></p>Formula:C9H16NO2·BrColor and Shape:White To Light GreyMolecular weight:250.132-(2-Aminoethylamino)ethanol
CAS:Controlled Product<p>Applications 2-(2-Aminoethylamino)ethanol is a reagent used in the synthesis of various pharmacologically active compounds and functional groups. Its used in the synthesis of antitumor anthracene-diones and antitumor DNA intercalators. More recently used in the synthesis of ionic liquids with various thermal, dielectric and catalytic properties.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bair, K. et al.: J. Med. Chem., 33, 2385 (1990); Krapcho, A. et al.: J. Med. Chem., 37, 828 (1994); Karadag, A. et al.: J. Mol. Liq., 177, 369 (2013);<br></p>Formula:C4H12N2OColor and Shape:NeatMolecular weight:104.1509(15R)-Bimatoprost
CAS:<p>Applications An intermediate in the production of Bimatoprost (B386800).<br></p>Formula:C25H37NO4Color and Shape:NeatMolecular weight:415.575-[[4-[3-(Aminocarbonyl)-1,4,5,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6H-pyrazolo[3,4-c]pyridin-6-yl]phenyl]amino]pentanoic Acid
CAS:<p>Applications Apixaban Open chain Acid Is an open ring impurity of Apixaban (A726700). Apixaben is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation.<br>References Luettgen, J.M. et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T. et al.: J. Thromb. Thrombol., 31, 310 (2011); barrett, Y.C. et al.: Thromb. Haemos., 105, 181 (2011);<br></p>Formula:C25H27N5O5Color and Shape:Light YellowMolecular weight:477.512-Oxo Clopidogrel Hydrochloride(Mixture of Diastereomers)
CAS:Controlled Product<p>Applications The essential intermediate metabolite from which the active metabolite of Clopidogel is formed.<br>References Feliste, R., et al.: Thromb. Res., 48, 403 (1987), Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Herbert, J., et al.: Cardiovasc Drug. Rev., 11, 180 (1993), Sugidachi, A., et al.: B. J. Pharmacol., 132, 47 (2001)<br></p>Formula:C16H17Cl2NO3SColor and Shape:NeatMolecular weight:374.28Tacrolimus (FK506)
CAS:<p>Applications An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Asano, K., et al.: In Vivo, 10, 537 (1996), McCall, E., et al.: Circ. Res., 79, 1110 (1996), Raufman, J.P., et al.: J. Biol. Chem., 271, 19877 (1996), Rokaw, M.D., et al.: Am. J. Physiol., 271, C194 (1996), Knoll, G.A., and Bell, R.C.: Brit. Med. J., 318, 1104 (1999)<br></p>Formula:C44H69NO12Color and Shape:NeatMolecular weight:804.02Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate
CAS:<p>Applications Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate is used in the synthesis of the major metabolites of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.<br>References Li, X., et. al.: Lett. Org. Chem., 12, 217 (2015); Vallu, V., et. al.: Anal. Chem. Indian J., 14, 339 (2014); Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993); Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003); Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005); Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005)<br></p>Formula:C13H13NO3SColor and Shape:NeatMolecular weight:263.31Edoxaban Tosylate Monohydrate
CAS:<p>Applications Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor.<br>References Ruff, C., et al.: Am. Heart J., 160, 635 (2010); Ogata, K., et al.: J. Clin. Pharm., 50, 73 (2010)<br></p>Formula:C31H38ClN7O7S2•xH2OColor and Shape:White To Off-WhiteMolecular weight:720.261,1'-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis[Theobromine]
CAS:Formula:C26H34N8O5Color and Shape:NeatMolecular weight:538.60Rivaroxaban
CAS:<p>Applications A novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formula:C19H18ClN3O5SColor and Shape:White To BeigeMolecular weight:435.88Tacrolimus Hydrate
CAS:<p>Applications Tacrolimus Hydrate is a disease-modifying antirheumatic drugs (DMARDs)<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ogasawara, M., et al.: Mod. Rheumatol., 22, 831-836 (2012)<br></p>Formula:C44H69NO12·H2OColor and Shape:NeatMolecular weight:822.03Sodium Chlorite (Technical Grade)
CAS:<p>Applications Sodium Chlorite is used as a bleaching agent for cotton textiles.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Shenai, V.A., Pai, S.M.: Textile Dyer Printer, 3, 153 (1969)<br></p>Formula:ClO2·NaColor and Shape:NeatMolecular weight:90.4416N-Demethylivabradine
CAS:Controlled ProductFormula:C26H34N2O5Color and Shape:Light Brown To BrownMolecular weight:454.56Ethyl 3-Amino-4-pyrazolecarboxylate
CAS:Controlled ProductFormula:C6H9N3O2Color and Shape:White To BeigeMolecular weight:155.15Macitentan
CAS:Controlled Product<p>Applications Macitentan, is an orally active endothelin receptor antagonist used for pulmonary arterial hypertension.<br>References Emoto, N. Ensho to Men'eki, 20, 487 (2012);<br></p>Formula:C19H20Br2N6O4SColor and Shape:White To Off-WhiteMolecular weight:588.27Trandolapril
CAS:Controlled Product<p>Applications An antihypertensive. Angiotensin converting enzyme (ACE) inhibitor.<br>References Brown, N.L., et al.: Eur. J. Pharmacol., 148, 79 (1988), Kober, L., et al.: N. Engl. J. Med., 333, 1670 (1995), Malik, R.A., et al.: Lancet, 352, 1978 (1998)<br></p>Formula:C24H34N2O5Color and Shape:NeatMolecular weight:430.54Rivaroxaban Diol
CAS:Controlled Product<p>Applications A metabolite of Rivaroxaban (R538000).<br>References Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005), Roehrig, S., et al.: J. Med. Chem., 48, 5900 (2005), Biemond, B., et al.: Thromb. Haemost., 97, 471 (2007), Lang, D., et al.: Drug Metab. Dispos., 37, 1046 (2009),<br></p>Formula:C19H20ClN3O6SColor and Shape:White To Off-WhiteMolecular weight:453.9Treprostinil Ethyl Ester
CAS:Controlled ProductFormula:C25H38O5Color and Shape:NeatMolecular weight:418.566N-Demethyl Ivabradine Hydrochloride
CAS:Controlled ProductFormula:C26H34N2O5·ClHColor and Shape:NeatMolecular weight:491.02Riociguat
CAS:Controlled Product<p>Applications Riociguat is used in the treatment for pulmonary hypertension.<br>References Frey, R. et al.: J. Clin. Pharmacol., 51, 1051 (2011);<br></p>Formula:C20H19FN8O2Color and Shape:NeatMolecular weight:422.4157Boc-L-Nitroarginine
CAS:Controlled Product<p>Applications Boc-L-Nitroarginine, can be used in peptide chemistry. It has been also shown to act as NO synthase inhibitor, and thus used in the study of The effects of methylene blue (MB) for treatment of sepsis induced by bowel perforation.<br>References Galili, Y. Euro. surg. Rese. vol. 29, P:390-395 (19997);<br></p>Formula:C11H21N5O6Color and Shape:NeatMolecular weight:319.31Repaglinide-ethyl-d5
CAS:Controlled Product<p>Applications Deuterated Repaglinide, a non-sulfonylurea oral hypoglycemic agent which is used as an antidiabetic.<br>References Wolffenbuttel, B.H.R., et al.: Eur. J. Clin. Pharmacol., 45, 113 (1993), Ampudia-Blasco, F.J., et al.: Diabetologia, 37, 703 (1994),<br></p>Formula:C272H5H31N2O4Color and Shape:White SolidMolecular weight:457.625-Chloro-2-thiophenecarboxylic Acid
CAS:Controlled Product<p>Applications 5-Chloro-2-thiophenecarboxylic Acid is a metabolite of Rivaroxaban (R538000).<br>References Brickner, S., et al.: J. Med. Chem., 39, 673 (1996), Sato, K., et al.: Eur. J. Pharmacol., 347, 231 (1998), Chang, P., et al.: IDrugs, 7, 50 (2004), Weinz, C., et al.: Drug Metab. Dispos., 37, 1056 (2009)<br></p>Formula:C5H3ClO2SColor and Shape:NeatMolecular weight:162.59S-(-)-Warfarin
CAS:Controlled Product<p>Applications The S-(-)-form of Warfarin (W498500). Coumarin anticoagulant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hagan, E.C., et al.: J. Am. Pharm. Assoc. Sci. Ed., 42, 379 (1953), Bell, R.G., et al.: Biochemistry, 11, 1959 (1972), Valente, J.E., et al.: J. Med. Chem., 20, 1489 (1977), Back, N., et al.: Pharmacol. Res. Commun., 10, 445, (1978), Babhair, S.A., et al.: Anal. Profiles Drug Subs., 14, 423 (1985), Takahashi, H., et al.: Echizen, Clin. Pharmacokinet., 40, 587 (2001),<br></p>Formula:C19H16O4Color and Shape:White SolidMolecular weight:308.33Trandolapril Diketopiperazine
CAS:Controlled Product<p>Impurity Trandolapril EP Impurity D<br>Applications Trandolapril Diketopiperazine (Trandolapril EP Impurity D) is a metabolite of the antihypertensive Trandolapril (Ru44570) (T713500), an angiotensin-converting enzyme inhibitor.<br>References Bakshi, M., et al.: J. Pharm. Biomed. Anal., 28, 1011 (2002), Cedrowska, I., et al.: Acta Pol. Pharm., 60, 141 (2003), Singh, S., et al.: J. Pharm. Biomed. Anal., 41, 1037 (2006),<br></p>Formula:C24H32N2O4Color and Shape:NeatMolecular weight:412.52Iomeprol-d3
CAS:Controlled Product<p>Applications Diagnostic aid (radiopaque medium).<br>References Gallotti, A., et al.: Eur. J. Radiol., 18, Suppl 1 S1(1994), Morisetti, A., et al.: Eur. J. Radiol., 18, Suppl 1 S21(1994).<br></p>Formula:C17H19D3I3N3O8Color and Shape:Off-WhiteMolecular weight:780.10Argatroban monohydrate
CAS:Controlled ProductFormula:C23H36N6O5S·H2OColor and Shape:NeatMolecular weight:526.653-((2-Chloroethyl)amino)propyl Dihydrogen Phosphate
CAS:Controlled Product<p>Impurity Ifosfamide EP Impurity A<br>Applications 3-((2-Chloroethyl)amino)propyl Dihydrogen Phosphate is a metabolite of Ifosfamide (I265000), which is a cytostatic drug.<br>References Gilard, V., et al.: J. Med. Chem., 42, 2542 (1999);<br></p>Formula:C5H13ClNO4PColor and Shape:WhiteMolecular weight:217.59Ramipril (1 mg/mL in Methanol)
CAS:Formula:C23H32N2O5Color and Shape:Single SolutionMolecular weight:416.51Diclofenac Levomenthol Ester
CAS:Controlled ProductFormula:C24H29Cl2NO2Color and Shape:NeatMolecular weight:434.399Iopromide-d3
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Labelled Iopromide. Nonionic, injectable radio-contrast medium. Diagnostic aid (radiopaque medium).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Muetzel, W., et al.: Am.J. Neuroradiol., 4, 350 (1983), Dawson, P., et al.: Acta Radiol. Diagn., 25, 253 (1984),<br></p>Formula:C18H21D3I3N3O8Color and Shape:White To Light YellowMolecular weight:794.13Tolvaptan
CAS:Controlled Product<p>Applications Tolvaptan is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000); Udelson, J., et al.: Circulation, 104, 2417 (2001); Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005); Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006);<br></p>Formula:C26H25ClN2O3Color and Shape:White To Off-WhiteMolecular weight:448.94Riluzole-13C,15N2
CAS:Controlled ProductFormula:C713CH5F315N2OSColor and Shape:Light Beige To Light YellowMolecular weight:237.18
![(3R,4E,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl(N-methylsulfonyl)amino]-pyrimidin-5-yl]-3…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-R1021.webp&w=3840&q=75)
![(E)-4-((1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopent-3-en-2-yl)amino)-4-oxobutanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-S18147.webp&w=3840&q=75)
![5-[[4-[3-(Aminocarbonyl)-1,4,5,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6H-pyrazolo[3,4-c]pyridin-6-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA875620.webp&w=3840&q=75)
![1,1'-[(5E)-5-Methyl-7-oxo-5-undecene-1,11-diyl] Bis[Theobromine]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM270000.webp&w=3840&q=75)
